These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 2659200

  • 21. Erythropoietin: issues in its use as a therapeutic for the anemia of chronic renal failure.
    Eschbach JW, Adamson JW.
    Blood Purif; 1990; 8(5):239-54. PubMed ID: 2091684
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.
    Stone WJ, Graber SE, Krantz SB, Dessypris EN, O'Neil VL, Olsen NJ, Pincus TP.
    Am J Med Sci; 1988 Sep; 296(3):171-9. PubMed ID: 3177433
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA, Verberckmoes R, Michielsen P, Koene RA.
    Nephrol Dial Transplant; 1989 Sep; 4(9):782-6. PubMed ID: 2516609
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A, Barrau J, Gómez Alamillo C, Jaurrieta F.
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V.
    Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin.
    Eschbach JW.
    Kidney Int; 1989 Jan; 35(1):134-48. PubMed ID: 2651751
    [No Abstract] [Full Text] [Related]

  • 34. Current and potential applications for erythropoietin.
    Pedrazzini A.
    Acta Haematol; 1992 Jan; 87 Suppl 1():2-3. PubMed ID: 1574962
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evidence-based recommendations for the clinical use of recombinant human erythropoietin.
    Muirhead N, Bargman J, Burgess E, Jindal KK, Levin A, Nolin L, Parfrey P.
    Am J Kidney Dis; 1995 Aug; 26(2 Suppl 1):S1-24. PubMed ID: 7645549
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
    Kulzer P, Schaefer RM, Krahn R, Schaefer L, Heidland A.
    Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A, Zehnder C.
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract] [Full Text] [Related]

  • 40. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB, Bárány P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougall IC, Pippard MJ, Shaldon S, van Wyck D.
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.